141 related articles for article (PubMed ID: 21907438)
21. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
22. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
23. Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT).
Jiang X; Li T; Liu Y; Zhou L; Xu Y; Zhou X; Gong Y
Radiat Oncol; 2011 Oct; 6():140. PubMed ID: 22014217
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
Wilson EM; Joy Williams F; Lyn BE; Aird EG
Radiother Oncol; 2005 Mar; 74(3):307-14. PubMed ID: 15763312
[TBL] [Abstract][Full Text] [Related]
25. On the possible benefits of a hybrid VMAT technique in the treatment of non-small cell lung cancer.
Agapito J
Med Dosim; 2013; 38(4):460-6. PubMed ID: 24094572
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
27. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
28. Hybrid IMRT for treatment of cancers of the lung and esophagus.
Mayo CS; Urie MM; Fitzgerald TJ; Ding L; Lo YC; Bogdanov M
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1408-18. PubMed ID: 18262730
[TBL] [Abstract][Full Text] [Related]
29. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
Han C; Schultheiss TE; Wong JYC
Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
[TBL] [Abstract][Full Text] [Related]
30. Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.
Silva SR; Surucu M; Steber J; Harkenrider MM; Choi M
Technol Cancer Res Treat; 2017 Apr; 16(2):224-230. PubMed ID: 27680023
[TBL] [Abstract][Full Text] [Related]
31. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
32. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
33. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
34. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric evaluation of a conformal seven-field coplanar technique for planning lung stereotactic body radiotherapy.
Richmond N; Green J; Peedell C; Shakespeare D; Walker C
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e24-30. PubMed ID: 21763114
[TBL] [Abstract][Full Text] [Related]
36. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
[TBL] [Abstract][Full Text] [Related]
37. Method of predicting the mean lung dose based on a patient׳s anatomy and dose-volume histograms.
Zawadzka A; Nesteruk M; Brzozowska B; Kukołowicz PF
Med Dosim; 2017 Spring; 42(1):57-62. PubMed ID: 28237293
[TBL] [Abstract][Full Text] [Related]
38. Volumetric modulated arc therapy (VMAT) comparison to 3D-conformal technique in lung stereotactic ablative radiotherapy (SABR).
Mark F; Alnsour A; Penfold SN; Esterman A; Keys R; Le H
J Med Radiat Sci; 2023 Mar; 70(1):72-80. PubMed ID: 36424510
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy for esophageal cancer using simultaneous integrated boost techniques: dosimetric comparison of helical TomoTherapy, Volumetric-modulated Arc Therapy (RapidArc) and dynamic intensity-modulated radiotherapy.
Wang YC; Chen SW; Chien CR; Hsieh TC; Yu CY; Kuo YC; Yang SN; Kao CH; Liang JA
Technol Cancer Res Treat; 2013 Dec; 12(6):485-91. PubMed ID: 23745789
[TBL] [Abstract][Full Text] [Related]
40. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
